11.07.2015 Views

Plenary Oral Presentations - Macquarie University Hospital

Plenary Oral Presentations - Macquarie University Hospital

Plenary Oral Presentations - Macquarie University Hospital

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

16 th International Meeting of the Leksell Gamma Knife ® SocietyMarch 2012, Sydney, AustraliaFU-151Gamma Knife Surgery for Hemifacial Spasm Related toCerebellopontine Angle Tumors1,2,5Chuan-Fu Huang, 1,2,4 Cheng-Siu Chang, 1,4 Hsien-Tang Tu, 1,3,4 Wen-Shan Liu1Gamma Knife Center2Department of Neurosurgery3Department of Radiation Oncology4Chung-Shan Medical <strong>University</strong> <strong>Hospital</strong>, Taichung, Taiwan5China Medical <strong>University</strong> <strong>Hospital</strong>, Taichung, TaiwanObjective: Most of tumor-related hemifacial spasm (HFS) reported was treated by open surgery. Wereport the effect of GKS on benign tumor-related HFS at a follow-up of 84 months.Methods: From 2000 to 2011, a total of 6 patients with cerebellopontine tumors (4 meningiomas, and2 schwannomas) with HFS underwent GKS as a primary treatment. These patients had tumors withinthe radiosurgical target area. For meningiomas, the mean radiosurgical treatment volume was 5.3 ml(range 1.2-9.2 ml), and the mean radiosurgical tumor margin dose was 14.1Gy (range 12-18 Gy); for 2schwannomas, the volume was 2.5 ml and 11.2 ml, and the marginal dose was 12 Gy. Five patients werefemale and one male. The mean duration of HFS was 15.5 months (range 3-36 months). The mean ageat the time of radiosurgery was 52.7 years (range, 45-60 years).Results: The mean follow-up period was 84 months (range 40 to 110 months). Overall, 4 of 6 patients(66 %) experienced complete HFS relief without medication after GKS and one patient had a goodoutcome. The mean time of the improvement was 7 months (range 2 to 18 months). Only one patienthad failed relief of HFS and coincidentally this tumor size was not shrunk. For all 6 patients (100%),there was tumor growth control at a mean follow-up of 56 months after GKS, four of them had tumorsize decreased and two were not changed. Two patients with facial numbness reported improvementafter tumor shrinkage.Conclusions: GKS appears to be an effective tool to treat benign tumor related HFS and control tumorgrowth. Reduction of tumor volume is related to spasInm improvement.26

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!